New hope for tough cancers: experimental drug JR8603 enters human trials
NCT ID NCT06783569
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 36 times
Summary
This early-stage trial tests an investigational drug called JR8603 in about 94 adults with advanced solid tumors (including stomach, junction, and colorectal cancers) whose prior treatments have stopped working. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants must have measurable disease and a life expectancy of at least 3 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Harbin Medical University Cancer Hospital
RECRUITINGHarbin, Heiljiang Province, 150040, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Liaoning Cancer Hospital
RECRUITINGShenyang, Liaoning, 110042, China
Contact
Conditions
Explore the condition pages connected to this study.